A Review of COVID-19-associated Fungal Infections

Kamali, Ali; Taheri Sarvtin, Mehdi

doi:10.18502/ijml.v11i2.18135

Write your message

ارسال به ایمیل

Volume 11, Issue 2 (May 2024) IJML 2024, 11(2): 117-129 | Back to browse issues page

‎ 10.18502/ijml.v11i2.18135

Mendeley

Zotero

RefWorks

Kamali A, Taheri Sarvtin M. A Review of COVID-19-associated Fungal Infections. IJML 2024; 11 (2) :117-129
URL: http://ijml.ssu.ac.ir/article-1-518-en.html

A Review of COVID-19-associated Fungal Infections

Ali Kamali

, Mehdi Taheri Sarvtin ^*

Department of Medical Mycology and Parasitology, School of Medicine, Jiroft University of Medical Sciences, Jiroft, Iran.

Abstract: (108 Views)

Acute respiratory coronavirus 2, the causative agent of the 2019 coronavirus disease (COVID-19), has been among the most important pathogens driving the healthcare delivery system in the past few years. Immunosuppressive drugs are used to treat this disease, and perhaps the nature of this disease has increased opportunistic infections in these patients. This study aims to investigate the number of fungal infections in patients with COVID-19. For this reason, keywords such as: “COVID-19”, “Aspergillus”, “fungi”, “Candida”, “Cryptococcus,” “Pneumocystis,” and “Mucorales” were searched. According to the investigation that was carried out, Aspergillus, Cryptococcus, Pneumocystis, Mucorales, and Candida were among the fungi that were investigated in patients with COVID-19. Lung damage, immunosuppression, need for oxygen therapy, steroid therapy, and hospitalization in intensive care units were known predisposing factors for fungal infections in these patients.

Keywords: Coronavirus, COVID-19, Fungal, Infections, SARS-CoV-2